Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
logo icon CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Medicilon is honored as TOP 20 R&D CRO Enterprises in China

2020-09-21
|
Page View:

Chongqing, September 10, 2020 – 2020 Conference on High Quality Development of Healthcare Industry & the Fifth China Pharmaceutical R&D and Innovation Summit was held successfully.  Attendees, including KOL and experts from pharmaceutical regulatory system, as well as enterprise executives and elites studying strategic management, project approval, investment evaluations and business trading for ages, shared and discussed topics concerning formulation development and pharmaceutical innovation.

During the conference, the sponsor announced six industry ranking lists, including 2020 TOP 20 R&D CRO Enterprise in China. Medicilon was nominated and ranked the 4th place on the list. This honor showed approval of progress and development Medicilon had made in the past, meanwhile motivating Medicilon to provide better services in the future.

Chinese-RD-CRO-Enterprises-in-2020
Return
Relevant newsRelevant news